Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Plos One|September 25, 2015
Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-AnalysisXinyu Qian, Jing Qin, Songdan Pan, et al.International Immunopharmacology|March 14, 2024
Integrative analysis and validation of necroptosis-related molecular signature for evaluating diagnosis and immune features in Rheumatoid arthritisWei Wan, Xinyu Qian, Bole Zhou, et al.The Journal of Surgical Research|June 4, 2014
Association between telomerase reverse transcriptase rs2736100 polymorphism and risk of gliomaPeng Zhou, Li Wei, Xiwei Xia, et al.Phytotherapy Research : PTR|June 30, 2026
Curcumol Inhibits the Laminin-Facilitated Malignant Progression in Small-Cell Lung Cancer via Disrupting Laminin-Integrin β1 InteractionJing Qin, Huanhuan Huang, Mengzhen Xu, et al.Mediators of Inflammation|May 11, 2026
Identification of Immune-Related Lactylation Genes in Rheumatoid Arthritis With Atherosclerosis: A Comprehensive Analysis Using Bulk and Single-Cell RNA Sequencing DataJiaqi Hu, Weiyu Tao, Xinyu Qian, et al.International Journal of Biological Macromolecules|November 11, 2025
Establishing the constitutive relationship between deep eutectic solvents pre-treatment extent, cellulose structure characteristics, and dissolution efficiency in lyocell processingMeiwen Zhang, Yuqian Guo, Yun Cheng, et al.Chemico-Biological Interactions|June 2, 2023
Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulationXinyu Qian, Lin Zhu, Mengzhen Xu, et al.Cardiovascular Diagnosis and Therapy|September 27, 2019
Total <i>Astragalus</i> saponins attenuates CVB3-induced viral myocarditis through inhibiting expression of tumor necrosis factor α and Fas ligandYunfeng Xiao, Tianlong Liu, Xiaoling Liu, et al.Frontiers in Pharmacology|May 20, 2020
Cost-Effectiveness of Zoledronic Acid Versus Oral Alendronate for Postmenopausal Osteoporotic Women in ChinaRuxu You, Yu Zhang, David Bin-Chia Wu, et al.Cancer Management and Research|December 12, 2019
Cost-Effectiveness Analysis Of EGFR Mutation Testing And Afatinib Versus Gemcitabine-Cisplatin As First-Line Therapy For Advanced Non-Small-Cell Lung Cancer In ChinaRuxu You, Jinyu Liu, David Bin-Chia Wu, et al.Pageof 4